This inventor holds 1 USPTO granted patent. Top assignee: Alchemia Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations of Thanh Le Giang in Monosaccharide Derivatives
Introduction
Thanh Le Giang is an accomplished inventor based in Mount Gravatt, Australia. He has made significant contributions to the field of biochemistry, particularly in the development of novel monosaccharide compounds. His work focuses on creating potentially biologically active compounds that could lead to new drug discoveries.
Latest Patents
Thanh Le Giang holds a patent for "Anomeric derivatives of monosaccharides." This invention relates to combinatorial libraries of potentially biologically active mainly monosaccharide compounds and methods of preparing them. The compounds are variously functionalized to vary lipid solubility, size, function, and other properties, with the aim of discovering drug or drug-like compounds with useful properties. The invention provides intermediates, processes, and synthetic strategies for the solution or solid-phase synthesis of monosaccharides, which are functionalized around the sugar ring, including the addition of aromaticity and charge, as well as the placement of amino acid and peptide side chain units of isosteres.
Career Highlights
Thanh Le Giang is associated with Alchemia Limited, where he continues to innovate in the field of biochemistry. His work has the potential to impact drug development significantly, making strides in the synthesis of biologically active compounds.
Collaborations
He has collaborated with notable colleagues, including Wim F Meutermans and Karl Schafer, to advance his research and development efforts.
Conclusion
Thanh Le Giang's innovative work in the field of monosaccharide derivatives showcases his commitment to advancing biochemistry and drug discovery. His contributions are paving the way for future developments in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile